Purpose of review: Nonoperating room anesthesia (NORA) procedures have expanded in number, variety, and complexity. NORA involves all age groups, including frail older adults and patients often considered too sick to tolerate traditional surgical interventions. Postoperative pulmonary complications are a significant source of adverse events in the perioperative setting. We present a review focused on preventing pulmonary complications in the interventional NORA setting. Recent findings: NORA locations should function as independent, autonomous ambulatory units. We discuss a strategic plan involving a thorough preoperative evaluation of patients, including recognizing high-risk patients and their anesthetic management. Finally, we offer guidance on the challenges of conducting sedation and anesthesia in patients with coronavirus disease 2019 (COVID-19) or a history of COVID-19. Summary: The demands on the interventional NORA anesthesia team are increasing. Strategic planning, checklists, consistent staffing assignments, and scheduled safety drills are valuable tools to improve patient safety. In addition, through quality improvement initiatives and reporting, NORA anesthetists can achieve reductions in periprocedural pulmonary complications.
It has been shown that the incidence of venous air embolism and venous carbon dioxide (CO2) embolism is high during endoscopic retrograde cholangiopancreatography (ERCP). We examined insufflating gas flow and maximum pressure produced by three types of commonly used endoscopes because we could not readily locate technical data for endoscope gas flow and maximum emitted pressure in the manufacturer's manuals. We tested the Olympus GIF-Q180 used for esophagogastroduodenoscopy, the CF-Q180 used for colonoscopy, and the TJF-Q180 used for ERCP (Olympus America Inc., Center Valley, Pennsylvania). Under three different clinical gas insufflation scenarios, we measured in vitro maximum gas pressure transduced from a closed space created at the endoscope tip in a worst-case scenario analysis. We showed that it is readily possible to generate a pressure (>5-30 times normal central venous pressure) in the air space at the tip of all three endoscopes when insufflation is activated and the gas egress is limited. These findings shed additional light on in vivo occurrences of gas embolism during gastrointestinal endoscopy. We postulate that in addition to using exclusively CO2 as the insufflating gas, the risk of gas embolism can be further diminished by regulating insufflating gas pressure at the tip of endoscopes.
Rapid infusion systems (RIS) are used to warm and rapidly infuse crystalloids and blood products. Current guidelines do not approve of platelet transfusion through a RIS, but data supporting these guidelines are scarce. Our hypothesis was that an infusion of whole blood through a RIS would degrade platelet quantity, impede viscoelastic clot strength, and inhibit platelet aggregation response to adenosine diphosphate pathway (ADP) activation. Ten iterations of a simulated scenario of transfusing whole blood via a single brand and make of RIS (Belmont Fluid Management System 2000, Belmont Medical Technologies, Billerica, MA) were performed. Units of whole blood, which were two to nine days old, were leukoreduced prestorage. Blood was used to prime the RIS and then warmed and infused at 100 mL/min into a reservoir. Blood samples were collected before and immediately after infusion. Samples were tested for platelet count, size, and viscoelastic clot strength using thromboelastographic and aggregation assays. The study sample (n = 10) included platelets with an average age of 5.3 days. The infusion through the RIS had a detrimental effect on all the maximal amplitudes (MA) of viscoelastic testing: MA ADP (mean difference = −18.7 mm; 95% CI: −24.1 to −13.3, P = 0.004), MA rapid thromboelastography (MA rTEG) (mean difference = −6.0; 95% CI: −10.0 to −2.0, P = 0.008), MA TEG (mean difference = −7.1; 95% CI: −10.9 to −3.4, P = 0.004), mean platelet volume (MPV) (mean difference = −0.3; 95% CI: −0.6 to −0.1, P = 0.02), and platelet count (mean difference = −68.3 × 103/µL; 95% CI: −86.9 to −49.7, P = 0.004). Platelet quantity, viscoelastic clot strength, and platelet aggregation response to ADP each decline after infusion through a RIS. Further studies regarding microaggregates and platelet activation are required.
We congratulate Dumonceau et al. on their recently published guideline on non-anesthesiologist administration of propofol for gastrointestinal (GI) endoscopy [1]. This is a well-crafted treatise with excellent current literature references that support their statements and recommendations. We would like to recommend a much stronger emphasis on ventilation monitoring for the next iteration of their guideline: from “consideration of capnography” to, instead, its requirement. Propofol exhibits a narrow therapeutic window for moderate to deep sedation to general anesthesia, and there is patient intervariability in terms of dose-related effects on respiratory drive. Safe use requires provider training, experience, and attention to objective real-time data from patient monitors. Dominceau et al. cite references that document safe use of propofol for endoscopic sedation without capnography, and some (Swiss and German) without routine blood pressure or electrocardiographic (ECG) monitors. Yet other European papers [2,3] suggest that serious, preventable anesthetic complications go significantly underreported. Our American experience provides insight into such higher potential risk of adverse events with propofol sedation for endoscopy when ventilation monitoring is not used. A study of the American Society of Anesthesiology Closed Claims Database confirmed that respiratory complications, specifically inadequate oxygenation and ventilation, occurred at nearly twice the rate in nonoperating room (NORA) locations, which include GI endoscopy, as it did in the main operating room where capnography is absolutely mandatory [4]. The GI suite was the source of 32 % of all NORA claims. The margin by which injury was considered preventable was 4:1 comparing NORA with the operating room, with deficiencies in pulse oximetry and/or capnography monitoring cited [4]. As NORA malpractice monetary awards in the USA run to double those of the main operating room, capnography seems to be a wise investment. With regard to European endoscopy practices that choose to forego blood pressure and/or ECG monitors for their propofol-sedated endoscopy patients, the acquisition and use of capnography monitoring would provide beneficial information about the adequacy of their patients’ blood pressure and cardiac output. For endoscopy practices with insufficient resources to invest in capnography monitors, we strongly counsel strict avoidance of supplemental oxygen. It is well proven that supplemental oxygen can mislead the practitioner by supporting excellent pulse oximetry saturation readings in the absence of effective ventilation [5]. As little as 2 L/min of nasal cannula oxygen flow maintains high oxygen saturation in the presence of dangerous levels of arterial carbon dioxide and significant respiratory acidosis. When using room air instead, the pulse oximeter becomes a much more sensitive and reliable indicator of hypoventilation [5]. In summary, we would strongly encourage routine use of capnography in all cases of non-anesthesiologist administration of propofol for GI endoscopy. We advocate the same standard for anesthesiologist-administered propofol. In situations where capnography is not available, the use of continuous supplemental oxygen should be discouraged because it can conceal significant compromise in ventilation.